Mind Cure Appoints Dr Ryan Hartwell As Chief Science Officer

Mind Cure Health (CSE: MCUR) has a new executive. The company this morning announced that appointment of Dr Ryan Hartwell as the firms Chief Science Officer. After months of serving on the firms scientific advisory board, Hartwell has taken the jump to lead the scientific team at the company.

A successful entrepeneur, scientist, inventor, and researcher, Hartwell appears to be highly qualified for the role. He previously founded ATS Biotech, a biomedical wound care company, while also acting as co-inventory of both FS2 and AI-001 cell therapy. Further, he also received the Vancouver Coastal Health Research Institute Award for top graduating doctoral student following the completion of his Ph.D. in experimental medicine at UBC.

Hartwell is to focus on the advancement of Mind Cure’s research and product development, and will be tasked with the role of leading efforts to research both psychoactive and psychedelic substances and their therapeutic benefits for the company. His role is to have a direct impact on establishing Mind Cure as a leader within the mental health space.

Commenting on the appointment, Hartwell stated, “From all that we have learned in studying psychedelics, the opportunity to chart a new path toward a better understanding and discovery of effective medicines provides tremendous potential to transform mental health and aging wellness.”

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Mind Cure Health last traded at $0.64 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Mind Cure Closes $3.6 Million Oversubscribed Financing

Mind Cure Health (CSE: MCUR) reported midday today that it has closed its non-brokered private...

Thursday, November 19, 2020, 04:28:12 PM

Mind Cure Closes Acquisition Deal, To Be Renamed LNG Energy

Mind Cure Health Inc. (CSE: MCUR) has closed the previously announced business combination with LNG...

Wednesday, August 16, 2023, 09:38:44 AM

Mind Cure Appoints Dr Wolfram Tetzlaff To Advisory Board

It appears that Mind Cure Health (CSE: MCUR) is not quite yet done compiling its...

Tuesday, October 13, 2020, 09:01:47 AM

Mind Cure Health Begins Research Into Psychedelic Compounds

Mind Cure Health (CSE: MCUR) has reached a milestone, with the company this morning announcing...

Tuesday, December 8, 2020, 08:04:33 AM

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics...

Tuesday, March 9, 2021, 08:43:32 AM